-
International Journal of Chronic Obstructive Pulmonary Disease
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Biological targets for therapeutic interventions in COPD: clinical potential
(2438) Views (638) Full article downloads
Authors: Girolamo Pelaia, Alessandro Vatrella, Luca Gallelli, Teresa Renda, Mario Caputi, et al
Published Date February 2006
Volume 2006:1(3) Pages 321 - 334
DOI: http://dx.doi.org/10.2147/COPD.S
Girolamo Pelaia1, Alessandro Vatrella2, Luca Gallelli1, Teresa Renda1, Mario Caputi2, Rosario Maselli1, Serafino A Marsico2 1Department of Experimental and Clinical Medicine, University "Magna Græcia" of Catanzaro, Italy; 2Department of Cardiothoracic and Respiratory Sciences, Second University of Naples, Italy
Abstract: COPD is a widespread inflammatory respiratory disorder characterized by a progressive, poorly reversible airflow limitation. Currently available therapies are mostly based on those used to treat asthma. However, such compounds are not able to effectively reduce the gradual functional deterioration, as well as the ongoing airway and lung inflammation occurring in COPD patients. Therefore, there is an urgent need to improve the efficacy of the existing drug classes and to develop new treatments, targeting the main cellular and molecular mechanisms underlying disease pathogenesis. These therapeutic strategies will be highlighted in the present review.
Keywords: COPD, bronchodilators, anti-inflammatory drugs, cytokine and chemokine antagonists, signal transduction inhibitors
Readers of this article also read:
Pulmonary stem cells and the induction of tissue regeneration in the treatment of emphysema
Influenza: the virus and prophylaxis with inactivated influenza vaccine in “at risk” groups, including COPD patients
Gender differences in the association between C-reactive protein, lung function impairment, and COPD
Outpatient pulmonary rehabilitation in patients with chronic obstructive pulmonary disease
Impairment of small airways in COPD patients with frequent exacerbations and effects of treatment with tiotropium
Long-term oxygen therapy: Are we prescribing appropriately?
The influence of the media on COPD patients’ knowledge regarding cardiopulmonary resuscitation
Knowledge and attitudes of family physicians coming to COPD continuing medical education
Corrigendum: Softec HD hydrophilic acrylic intraocular lens: biocompatibility and precision
- Journal Indexing
See where all the Dove Press journals are indexed
- Testimonials
"You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio
- Clinical effectiveness of the Respimat® inhaler device in managing chronic obstructive pulmonary disease: evidence when compared with other handheld inhaler devices
- Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity
- The pathophysiology of bronchiectasis
- Exacerbation rate, health status and mortality in COPD – a review of potential interventions




